581 followers
MA: rTMS targeting DLPFC is effective in reducing the comorbid anxiety (g=0.3; 0.11-0.48) and depression symptoms (0.24; 0.07-0.40) along with OCD severity (0.43; 0.20-0.65). The change in anxiety was moderated by a change in OCD https://t.co/nqQqXdjr6b